Product How it works Pricing Blog FAQ About Contact
Zoetis

Zoetis (NYSE: ZTS) net income

Zoetis reported a net profit of $2,673m for fiscal 2025, 7.5% more than in fiscal 2024 ($2,486m). Its net margin was 28.2%. Earnings per share were $6.03.

Net income, in millions of US dollars821.02016864.020171,42820181,50020191,63820202,03720212,11420222,34420232,48620242,6732025

Net income by fiscal year

Fiscal yearNet incomeChangeNet marginEarnings per share
2025$2,673m+7.5%28.2%$6.03
2024$2,486m+6.1%26.9%$5.47
2023$2,344m+10.9%27.4%$5.08
2022$2,114m+3.8%26.2%$4.51
2021$2,037m+24.4%26.2%$4.29
2020$1,638m+9.2%24.5%$3.44
2019$1,500m+5.0%24.0%$3.14
2018$1,428m+65.3%24.5%$2.96
2017$864.0m+5.2%16.3%$1.76
2016$821.0m—16.8%$1.66

The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.

Questions about the net income of Zoetis

How much did Zoetis earn in fiscal 2025?
Zoetis reported a net profit of $2,673m for fiscal 2025. In fiscal 2024 it reported a net profit of $2,486m.
What are the earnings per share of Zoetis?
They were $6.03 in fiscal 2025, compared with $5.47 in fiscal 2024.
What is the net margin of Zoetis?
In fiscal 2025 its net profit was 28.2% of its revenue.
What was the most profitable year for Zoetis?
Of its last 10 fiscal years, fiscal 2025, with $2,673m.
Where do the figures for Zoetis come from?
From the annual report (Form 10-K) that Zoetis files with the SEC, the US securities regulator. Each fiscal year links to its filing.

Where each figure comes from

From the annual report (Form 10-K) that Zoetis files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Zoetis: the Zoetis page · annual accounts · revenue · insider transactions.

Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.